Thrombosis Research

Article	Citations
Is all collagen the same for platelet testing? Editorial on “Platelet collagen receptors and their role in modulating platelet adhesion patterns and activation on alternatively processed collagen subs	72
Distinct Immunologic Mediators Are Associated with Venous Thromboembolism in Multiply Injured Patients	60
Crosstalk between hemostasis and immunity in cancer pathogenesis	56
The role of interleukin-10 gene variants in inhibitor development in hemophilia: A meta-analysis	48
Acute and subacute effects of strenuous exercise on platelet aggregation, coagulation and fibrinolysis in patients with stable coronary artery disease	46
Rivaroxaban plus aspirin versus acenocoumarol to manage recurrent venous thromboembolic events despite systemic anticoagulation with rivaroxaban	44
Corrigendum to “Repurposing of rilpivirine for preventing platelet β3 integrin-dependent thrombosis by targeting c-Src active autophosphorylation” [Thromb. Res. 229 (2023) 53–68]	44
PO-08: Characterisation of plasma extracellular vesicles in myeloproliferative neoplasms	42
A novel role of acellular hemoglobin in hemolytic thrombosis	42
PO-51: Kaposiform hemangioendothelioma is associated with platelet functional abnormalities that persist in patients even after complete blood cell count recovery	41
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination	40
Major in-hospital bleeding in patients with pulmonary embolism treated with systemic thrombolysis	36
DOACs: A perfect fit for patients with bariatric surgery?	34
PO-39: Superior vena cava stenting: an effective and safe therapeutic choice for the treatment of superior vena cava syndrome in lung cancer patients	34
Decreased patency of transjugular intrahepatic portosystemic shunts performed for splanchnic vein thrombosis in patients with myeloproliferative neoplasms	33
Regulation of fibrinogen synthesis	31
Linezolid impair proplatelet formation by reducing mitochondrial energy metabolism in MEG-01 cells	31
Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention	30
Investigation of the impact of antithrombin deficiency on the inflammatory response: Results from a single centre cohort study	30
Cost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study	30
Unveiling the predictive capacity of inflammatory and platelet markers for central retinal artery occlusion	29
Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice	29
Assessing the risk of venous thromboembolism in trans masculine persons on gender-affirming hormone therapy: A literature review	29
Editorial Board	28
Clonal hematopoiesis and cardiovascular disease in cancer patients and survivors	28

Predicting post-discharge venous thromboembolism and bleeding among medical patients: External validation of a novel risk score utilizing ubiquitous biomarkers	28
Cyclophosphamide vs rituximab for eradicating inhibitors in acquired hemophilia A: A randomized trial in 108 patients	26
Myocardial ischemia-reperfusion injury released cellular fibronectin containing domain A (CFN-EDA): A destructive positive loop amplifying arterial thrombosis formation and exacerbating myocardial rep	25
In vitro procoagulant effects of Gla-domainless factor Xa in factor XI-deficient and factor IX-deficient plasma	25
Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports	25
Pulmonary embolism: Age specific temporal trends in incidence and mortality in Denmark 1999–2018	25
Don't let D-dimer fool you: Elevated D-dimer plasma levels should not imply ‘hyperfibrinolysis’	25
Prosthetic valve dysfunction in patients with mechanical heart valves: Results from the Emergency Salam Centre cohort	25
The maternal hemostatic shift: Understanding VTE risk in pregnancy and postpartum	25
Driver gene KRAS aggravates cancer-associated stroke outcomes	24
Venous thromboembolism in hematopoietic stem cell transplantation: A narrative review	24
D-dimer as a predictive biomarker for cancer-associated thrombosis: A prospective cohort study	23
Canadian Perspective on Superficial Vein Thrombosis in Pregnancy and Postpartum: Interim Results from a Tertiary Care Centre	23
A survey on clinical practice in monitoring and management of bleeding in children with haemophilia A on emicizumab prophylaxis in the PedNet centres	22
Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large p	22
Editorial Board	21
A comprehensive review of the autoimmune pathogenesis of acquired hemophilia A	21
Letter to the editor regarding the article “Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes”	21
PO-18: Myocardial infarction and risk of cancer	20
PO-22: Rate of venous thromboembolism events in cancer patients treated by radiation therapy: the Radiation-Induced Thrombosis study	20
Pulmonary embolism bleeding score index (PEBSI): A new tool for the detection of patients with low risk for major bleeding on thrombolytic therapy	20
CT coronary calcium score is a prognostic marker in acute pulmonary embolism	20
Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban	20
Risk factors for thrombocytopenia in adult patients with sepsis: A systematic review and meta-analysis	20
PO-60: Comparison of inferior vena cava (IVC) filter use and outcomes between cancer and non-cancer patients in a single-center cohort	20
Predicting functional outcomes after acute ischemic stroke – Is thrombelastography useful outside perioperative bleeding management?	20
Comparison of absolute immature platelet count to the PLASMIC score at presentation in predicting ADAMTS13 deficiency in suspected thrombotic thrombocytopenic purpura	20
PO-56: Low molecular weight heparin beyond 12 months in patients with cancer associated thrombosis: CAT-LONG study	19
Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: Insights from CURES	19
Does thromboelastography predict bleeding in patients treated with clopidogrel or ticagrelor in off-pump coronary artery bypass grafting?	19
Vaccine-induced immune thrombotic thrombocytopenia and patients with cancer	19
Preface to the Proceedings of the 11th International Conference on Thrombosis and Hemostasis Issues in Cancer, 2022	19
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results	19
Safety of fixed-dose heparin titration boluses in underweight patients	19
PO-40: Therapeutic approaches of superior vena cava syndrome in patients with non-small cell lung cancer (NSCLC)	19
Clinical and genetic features of Chinese pediatric patients with severe congenital protein C deficiency who first presented with purpura fulminans: A case series study and literature review	19
Control of warfarin treatment in patients with antiphospholipid syndrome and falsely high INR at point-of-care-testing	18
Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura	18
To aPTT or not to aPTT: Evaluating the optimal monitoring strategy for unfractionated heparin	18
Statin use and mortality in patients with deep vein thrombosis. Data from the RIETE Registry	18
Real-time risk stratification in acute pulmonary embolism: the utility of RV/LV diameter ratio	18
Performance of the Bova score in predicting short-term all-cause mortality in patients with pulmonary embolism and normal blood pressure. A systematic review and meta-analysis	18
Influence of sex on development of thrombosis in patients with COVID-19: From the CLOT-COVID study	18
The role of platelets in heat-related illness and heat-induced coagulopathy	18
Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors	18
Association between neutrophil extracellular traps (NETs) and thrombosis in antiphospholipid syndrome	17
Intracoronary antithrombotic therapy during primary percutaneous coronary intervention in patients with STEMI: A systematic review and network meta-analysis	17
Editorial Board	17
Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination	17
Mental, emotional and social dimensions of quality of life and their relationship with physical and functional status in adults with haemophilia	17

Editorial Board	17
Barriers and facilitators for adherence to direct oral anticoagulants in patients with atrial fibrillation: A qualitative approach	16
Thromboelastography as a predictor of functional outcome in acute ischemic stroke patients undergoing endovascular treatment	16
OC-10: Plasmatic von Willebrand factor encapsulates blood circulating melanoma cells to prevent their hematogenous metastasis	16
Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase	16
Thrombin generation assay in venous thromboembolism: A scoping review	15
Rotational thromboelastometry as a biomarker for mortality — The Maastricht Intensive Care COVID cohort	15
Risk of venous thromboembolism in women with endometriosis	15
Effect of lupus anti-coagulant and antiphospholipid antibodies on clot waveform analysis parameters	15
Evaluation of modified pediatric sepsis-induced coagulopathy score in pediatric septic shock	15
Abstracts from the CanVECTOR 2024 Annual Conference October 25th, 2024	15
Anticoagulation plus antiplatelet therapy versus anticoagulation alone following iliac vein stent implantation in acute and subacute deep vein thrombosis: A multicenter study with propensity score mat	15
Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes	15
Procoagulant phenotype induced by oxidized high-density lipoprotein associates with acute kidney injury and death	15
Optimizing therapeutic enoxaparin in preterm neonates and infants	15
Stroke mortality in cancer survivors: A population-based study in Japan	15
Association between the simplified Pulmonary Embolism Severity Index (sPESI) score and hospitalization in emergency department patients diagnosed with pulmonary embolism	15
Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials	15
Long-term recurrence, bleeding, and mortality after first-time subsegmental pulmonary embolism compared to more proximal pulmonary embolism: Findings from the TROLL registry	14
Incidence and impact of venous thromboembolism in hospitalized patients with Crohn's disease	14
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trial	14
SSA-sMLP: A venous thromboembolism risk prediction model using separable self-attention and spatial-shift multilayer perceptrons	14
Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis	14
Elevated plasma levels of factor VIII enhance arterial thrombus formation on erosive smooth muscle cell-rich neointima but not normal intima in rabbits	14
Extracellular histones promote retraction and impair lysability of platelet-rich clots	14
Accuracy of physical examination in detecting central venous catheter-associated thrombosis in critically ill children	14
The long haul COVID-19 arterial thrombosis	14
A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand disease	14
A Predictive Model to Identify Pulmonary Embolism in Unselected Emergency Department Patients: Model Validation and Improvement During the COVID Era	14
Editorial Board	14
Suitability and readiness assessment of organizational resources for the implementation of gene therapy in hemophilia in Spain and Portugal: A survey-based study	14
Hsa_circ_0001020 accelerates the lower extremity deep vein thrombosis via sponging miR-29c-3p to promote MDM2 expression	14
18F-Fluorodeoxyglucose positron emission/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: What do we know?	13
Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) stud	13
Risk factors for hospital acquired venous thromboembolism in congenital heart disease patients: A report from the children's hospital acquired thrombosis (CHAT) consortium	13
Safety and efficacy of apixaban as thromboprophylaxis in myeloma patients receiving chemotherapy: A prospective cohort study	13
Recurrent mechanical prosthetic valve thrombosis: Another clinical challenge	13
Performance of age-adjusted and fixed threshold D-dimer to exclude DVT in those with low pre-test probability – Single centre experience	13
PO-37: A study of the evolution of radiological features of untreated small volume pulmonary embolism (PE) in cancer patients	13
Critique and advice of a multicenter mechanical thrombectomy registry in intermediate-risk PE	13
PO-30: Chemotherapeutic agents temozolomide and lomustine induce procoagulant activity of glioblastoma cell lines in vitro	13
PO-23: Upper extremity deep vein thrombosis in cancer patients: our experience	13
Clinical and economic burden of immune tolerance induction in entire patients with hemophilia A: Insights from a real-world Korean setting	13
Reference values of coagulation assays performed for thrombophilia screening after a first venous thrombosis and their intra-patient associations	13
Platelets provide robustness of spatial blood coagulation to the variation of initial conditions	12
PO-57: Venous thromboembolism recurrence during anticoagulant treatment in gastrointestinal cancer patients	12
PO-63: Edoxaban effect in a breast cancer patient with liver arterial infusion chemotherapy (LAIC) and both jugular vein and hepatic artery thrombosis: a unique clinical case	12
PO-29: Coagulation and circulating tumour cells as pharmacodynamic biomarkers of response to aromatase inhibitors in breast cancer	12
Outcomes of IVF treatments in women with antiphospholipid antibodies or antiphospholipid syndrome	12
ROS-driven structural and functional fibrinogen modifications are reverted by interleukin-6 inhibition in Giant Cell Arteritis	12
Trends in ischemic heart disease and thromboembolism-related mortality in the United States, 1999–2024: A population-based analysis using CDC WONDER Data	12
The course of pulmonary embolism in individuals recovered from COVID-19	12
Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study	12
PO-47: Prevention and treatment of recurrent trombosis after reconstruction of major vessels	12
Editorial Board	12
Editorial Board	12
DOAC Score for prediction of major bleeding in patients with venous thromboembolism: Findings from the RIETE registry	12
Acquired von Willebrand syndrome secondary to lymphoproliferative disorders: A case series from two French centers	12
The Attend-PE model: A feasibility study of a structured follow-up care model for patients with pulmonary embolism.	12
DOACs plasma levels in relation to clinical outcome. How far have we come?	12
The influence of metastasis on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: A pre-specified subgroup analysis from the ONCO DVT study	12
Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles	12
Newly developed modified diluted prothrombin time reagent: A multi-centre validation in patients with non-valvular atrial fibrillation under direct oral anticoagulant therapy	12
Hemostatic considerations for gender affirming care	12
Venous thromboembolism in women with hormone-dependent breast cancer. To continue or discontinue hormonal treatment? Insights from the RIETE registry	12
Treating the mind and body: implementation of a psychosocial wellbeing assessment in the deep vein thrombosis clinic	12
Protein disulfide isomerase 1 (PDIA1) regulates platelet-derived extracellular vesicle release	12
Thrombocytopenia is associated with a dysregulated host response in severe COVID-19	12
PO-54: Preliminary evaluation of venous thromboembolic risk in patients with colorectal cancer from the CARTAGO study	12
The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia	12
Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors	11
Air pollution impacts on in-hospital case-fatality rate of ischemic stroke patients	11
A novel F7 mutation (p.Gly217Arg) associated with infantile intracranial hemorrhage successfully managed with rFVIIa	11
Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation	11
Mitochondrial DNA copy number and its association with venous thromboembolism in patients with cancer	11
Perinatal stroke and hypofibrinogenemia: Is the new missense fibrinogen variant γ p.Gly310Glu the cause of the procoagulant state?	11
Increased contact system activity three months after starting combined oral contraceptives	11
Risks of bleeding and thromboembolic events in patients undergoing colonoscopy on uninterrupted and interrupted anticoagulant therapy in real-world setting	11
Characteristics and outcome of a territory-wide cohort study of patients with acquired hemophilia A in Hong Kong	11
The contact system in chronic kidney disease and hemodialysis – A cross-sectional study	11

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial	11
Differential regulation of human thrombospondin-1 upon systemic desmopressin versus endotoxin challenge	11
Identification of hematuria with a natural language processing model and validation of hematuria diagnosecodes	11
A systematic review and meta-analysis of periprocedural bridging for patients with mechanical heart valves undergoing non-cardiac interventions	11
Evaluation of definitions for oral anticoagulant-associated major bleeding: A population-based cohort study	11
Trends of hospital admissions due to acute limb ischemia and venous thromboembolism in Austria: A population-wide observational analysis from 2009 to 2023	11
Association between coagulation activity and clinical and imaging outcomes in acute ischemic stroke patients - A sub-study of the MR CLEAN NO-IV trial	11
Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19	11
Shiga toxin down-regulates ERG protein in endothelial cells and impairs angiogenesis	11
Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER)	11
Thymidine phosphorylase mediates SARS-CoV-2 spike protein enhanced thrombosis in K18-hACE2TG mice	11
Adjusted global antiphospholipid syndrome score (aGAPSS) is useful to predict relapses in patients with retinal vein occlusion	10
Prognostic role of serial electrocardiographic changes in patients with acute pulmonary embolism. Data from the Italian Pulmonary Embolism Registry	10
CIB1 and platelet integrin αIIbβ3: Molecular mechanisms, disruption strategies and antithrombotic opportunities	10
Tissue factor expression in monocyte subsets during human immunothrombosis, endotoxemia and sepsis	10
Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2	10
Natural history of untreated acute pulmonary embolism in patients with cancer: A retrospective cohort of missed pulmonary emboli	10
PO-04: Thrombin generation and D-dimer significantly predict for early disease progression and mortality in patients with gastrointestinal cancer	10
COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data	10
Added IMPACT: The first successful natural birth using certolizumab in obstetric APS	10
PO-11: Risk of major bleeding in cancer patients with ischemic stroke treated with thrombolysis	10
Efficacy and safety of antithrombin or recombinant human thrombomodulin in the treatment of disseminated intravascular coagulation: A systematic review and meta-analysis	10
Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registry	10
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence	10
Who are we bridging? Description of warfarin patients receiving injectable bridging therapy	10
CXCL13/CXCR5 axis facilitates TFH expansion and correlates with disease severity in adults with immune thrombocytopenia	10
Long-term clinical outcomes in older patients with acute venous thromboembolism who have renal impairment	10
Editorial Board	9
A real-world pharmacovigilance analysis of the FDA adverse event reporting system database for emicizumab	9
Prognosis after cerebral venous thrombosis: Mortality during initial admission and at 30 days and one year after discharge in a large Canadian population-based cohort	9
Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension	9
Copyright	9
Editorial Board	9
Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort study	9
Prognostic value of an automated thrombin generation assay in COVID-19 patients entering hospital: A multicentric, prospective observational study	9
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation - A meta-analysis	9
Dynamics of troponins and 30-day mortality in hospitalized patients with pulmonary embolism	9
Management of venous thromboembolism in stroke: A deep appraisal exposing discordance in guideline quality and recommendations	9
Scoping review of current evidence on the incidence of Venous thromboembolism (VTE) in the East Asian population	9
Effect of regular exercise training on platelet function in patients with cardiovascular disease and healthy individuals: A systematic review	9
COVID-19 venous thromboembolism prophylaxis guidelines in pediatrics	9
Editorial Board	9
Molecular basis of clot retraction and its role in wound healing	9
Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis	9
Neutrophil extracellular traps formation may be involved in the association of propranolol with the development of portal vein thrombosis	9
Erythrocyte rheology is altered in haemophilia patients with advanced arthropathy. A case-control study	9
Understanding European patterns of deprescribing antithrombotic medication during end-of-life care in patients with cancer	9
Anti-Xa Levels with Venous Thromboembolism Prophylaxis in Critical Care: A Systematic Review and Meta-Analysis	9
Dielectric blood coagulometry to evaluate coagulation activity in patients prescribed factor Xa inhibitors undergoing elective surgery: A prospective observational study	9
In-hospital outcomes of Ticagrelor versus Clopidogrel in high bleeding risk patients with acute coronary syndrome: Findings from the CCC-ACS project	8
Prothrombotic plasma fibrin clot phenotype is associated with spontaneous echo contrast in atrial fibrillation: The role of protein carbonylation	8
Long term recovery of right ventricular function after treatment of intermediate and high risk pulmonary emboli	8
The heat shock protein DNAJB2 as a novel biomarker for essential thrombocythemia diagnosis associated with immune infiltration	8
Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer	8
Acquired factor XI deficiency in paediatrics patients: A French series and review of literature cases	8
Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study	8
Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated pro	8
Editorial Board	8
Risk of thromboembolism according to statin treatment in patients with cancer: A nationwide nested case-control study	8
Prothrombin complex concentrate for direct factor Xa inhibitor-associated bleeding or before urgent surgery	8
Modest performance of risk-prediction models for anticoagulant-related bleeding in patients with chronic liver disease	8
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study	8
The differential formation and composition of leukocyte-platelet aggregates induced by various cellular stimulants	8
SARS-CoV-2 infection, vaccination and acquired hemophilia: Correspondence	8
Defibrotide mitigates endothelial cell injury induced by plasmas from patients with COVID-19 and related vasculopathies	8
Epigenetic repression of THBD transcription by BRG1 contributes to deep vein thrombosis	8
Osimertinib-related venous thromboembolism in non small lung cancer	8
Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study	8
Disulfide bond control of platelet αIIbβ3 integrin	8
To clot, or not to clot: The dilemma of hormone treatment options for menopause	8
von Willebrand factor and fibrin monomer - induced septic shock coagulation typing: Clinical comparison between thrombotic thrombocytopenic purpura - like syndrome and sepsis - induced coagulopathy wi	8
Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients	8
Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis	8
A RIETE registry analysis of patients with upper extremity deep vein thrombosis and thoracic outlet syndrome	8
Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study	8
Platelet and endothelial cell activation in antiretroviral therapy-treated African women living with HIV and obesity	8
JAK2V617F-positive extracellular genomic materials drive endothelial inflammation and thrombosis in myeloproliferative neoplasms	8
Is pulmonary embolism occurring after SARS COV-2 vaccination provoked or unprovoked?	8
Anticoagulation with argatroban using hemoclot™ targets is safe and effective in CARDS patients receiving venovenous extracorporeal membrane oxygenation: An exploratory bi-centric cohort study	8
20-HETE induced platelet activation via a GPR75-independent pathway	8
Thrombectomy in high-risk pulmonary embolism – device versus thrombolysis: rationale and design of the TORPEDO-NL investigator-initiated, academically-sponsored, multicenter, open-label randomized con	8
Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis	8
Management options for pediatric venous thromboembolic disease: Beyond anticoagulation with endovascular therapies	8
Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism	8
The efficacy and safety of andexanet alfa in the treatment of anticoagulation-related major bleedings: An Italian perspective	8
Development and validation of a clinical prediction model for post thrombotic syndrome following anticoagulant therapy for acute deep venous thrombosis	8
Depression and anxiety up to two years after acute pulmonary embolism: Prevalence and predictors	8
Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial	8
PO-43: Pharmacological thromboprophylaxis to prevent venous thromboembolism in ambulatory patients with cancer undergoing antineoplastic drugs in real world clinical practice: a cohort study	8
Early immune tolerance induction is a unique predictor of favorable outcomes in hemophilia A children with intron 22 inversion and high-responding inhibitors	8
PO-24: Incidence of venous thromboembolism following head and neck surgery stratified according to cancer: a Danish nation-wide cohort study	8
Corrigendum to “Rho-kinase inhibitor treatment prevents pulmonary inflammation and coagulation in lipopolysaccharide-induced lung injury” [Thromb. Res. 150 (2017) 59–64]	7
Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome	7
Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice	7
White blood cell subtypes and neutrophil extracellular traps as biomarkers for stroke etiology	7